Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%

Zinger Key Points
  • Century shares scales a one-month high.
  • Shares moves the most in 11-months on a single day basis.

Shares of Century Therapeutics Inc IPSC zoomed by 20.74% to $1.63 per share on Wednesday, which is the highest price move in nearly a month since Oct. 1. The shares also rose the most in over 11 months since Dec. 6, 2023, in a single day.

Also read: Trump’s Tariff Threat To Canada May Disrupt Oil Markets, Inflate Prices: ‘Would Likely Raise The Price Of Fuels,’ Says Analyst

What Happened: On Wednesday, Casdin Capital acquired an additional 1,380,000 shares in Century Therapeutics raising its stake by nearly 43% in the biotechnology company, as per an SEC filing.

After the transaction, Casdin Capital owns a total of 4,592,316 shares, or 5.4% in Century Therapeutics. According to the filing, Century shares were acquired for $1.35 apiece. Century Therapeutics represents 0.12% of Casdin’s portfolio after the transaction.

Why It Matters: Century shares jumped by nearly 21%, the most in a single day since Dec. 6, 2023, when it had jumped by 36% after the transaction.

Casdin Capital, LLC, a New York-based investment firm, specializes in biotechnology investments. With a $1.5 billion equity portfolio, its top holdings include BioLife Solutions Inc (BLFS) and Sarepta Therapeutics Inc (SRPT).

Image via Unsplash

Read Next:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EquitiesMarketsBiotechcasdin capitalcentury therpeuticspharmashare pricestock move
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!